McKesson

McKesson Corporation provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. The Company operates in two segments. The McKesson Distribution Solutions segment delivers ethical drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells financial, operational and clinical solutions for pharmacies (retail, hospital, long-term care) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management and software solutions. In July 2011, the Company acquired Portico Systems from Safeguard Scientifics, Inc. On March 25, 2012, it acquired the independent banner and franchise businesses of Katz Group Canada Inc.

McKesson Distribution Solutions delivers pharmaceuticals to retail pharmacies and institutional providers like hospitals and health systems. They operate pharmaceutical distribution centers across the country, serving customers in all 50 states. They also deliver a comprehensive offering of health care products, technology, equipment and related services to the alternate site market, including physician offices, surgery centers, long-term care facilities and home care businesses across the country. McKesson is currently the largest pharmaceutical distributor in North America. McKesson also operates McKesson Canada and has an equity holding in Nadro, a leading distributor in Mexico.

McKesson, established in 1833 and headquartered in United States, North America., specializes in Early Stage Venture, Private Equity investments across Life Science, Analytics, Health Care, Pharmaceutical, Information Technology, Risk Management, Cloud Data Services, Apps, Medical, Oncology. The organization boasts a portfolio of 3 investments, with an average round size of $9.3M and 1 successful exits. Their recent investments include SHYFT, Medidata, OncoHealth, Arsenal Capital Partners, Xealth. The highest investment round they participated in was $1.7B. Among their most notable exits are SHYFT and Medidata. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.